Vitamin D Supplementation and Neurocognition

• Status: Withdrawn
• Trial end date: 2020-02-24
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the effect of vitamin D supplementation on the neurocognitive function of older people with lower than normal levels of vitamin D at baseline

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Rambam Health Care Campus
• Treatments: Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Adults aged 65 years and older.

• Level of vitamin D (25-OH vitamin D) is less than 30 ng / ml.

• Stable health status as assessed by the treating primary care physician.

• Do not take supplements containing vitamin D.

• Normal cognitive function as determined by MoCA Test screening and clinical assessment

• Adequate literacy to enable the performance of cognitive assessment instruments

• Provide informed consent as required by the Ethics Committee.

Exclusion Criteria:

• Age younger than 65 years

• Health status not stable as determined by the treating primary care physician

• A diagnosis of dementia

• Taking supplements containing Vitamin D

• Significant visual or hearing impairment not corrected by spectacles or hearing aids

• Impaired competency limiting the subject's ability to provide informed consent